These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study. Moss EB; Buys YM; Low SA; Yuen D; Jin YP; Chapman KR; Trope GE J Glaucoma; 2017 Feb; 26(2):182-186. PubMed ID: 27096722 [TBL] [Abstract][Full Text] [Related]
10. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial. Brandt JD; VanDenburgh AM; Chen K; Whitcup SM; Ophthalmology; 2001 Jun; 108(6):1023-31; discussion 1032. PubMed ID: 11382623 [TBL] [Abstract][Full Text] [Related]
11. Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study. Brandt JD; Sall K; DuBiner H; Benza R; Alster Y; Walker G; Semba CP; Ophthalmology; 2016 Aug; 123(8):1685-1694. PubMed ID: 27157843 [TBL] [Abstract][Full Text] [Related]
12. Randomized trial of brinzolamide/brimonidine versus brinzolamide plus brimonidine for open-angle glaucoma or ocular hypertension. Gandolfi SA; Lim J; Sanseau AC; Parra Restrepo JC; Hamacher T Adv Ther; 2014 Dec; 31(12):1213-27. PubMed ID: 25430900 [TBL] [Abstract][Full Text] [Related]
13. A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension. Schachar RA; Raber S; Courtney R; Zhang M Curr Eye Res; 2011 Sep; 36(9):809-17. PubMed ID: 21851167 [TBL] [Abstract][Full Text] [Related]
14. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. Topouzis F; Melamed S; Danesh-Meyer H; Wells AP; Kozobolis V; Wieland H; Andrew R; Wells D Eur J Ophthalmol; 2007; 17(2):183-90. PubMed ID: 17415690 [TBL] [Abstract][Full Text] [Related]
15. Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering. Simmons ST; Earl ML; Ophthalmology; 2002 Feb; 109(2):307-14; discussion 314-5. PubMed ID: 11825814 [TBL] [Abstract][Full Text] [Related]
16. Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. Slakter JS; Bochow TW; D'Amico DJ; Marks B; Jerdan J; Sullivan EK; Robertson SM; Slakter JS; Sullins G; Zilliox P; Ophthalmology; 2006 Jan; 113(1):3-13. PubMed ID: 16368146 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure. Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study. Aung T; Wong HT; Yip CC; Leong JY; Chan YH; Chew PT Ophthalmology; 2000 Jun; 107(6):1178-83. PubMed ID: 10857840 [TBL] [Abstract][Full Text] [Related]
19. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448 [TBL] [Abstract][Full Text] [Related]
20. Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1). Medeiros FA; Walters TR; Kolko M; Coote M; Bejanian M; Goodkin ML; Guo Q; Zhang J; Robinson MR; Weinreb RN; Ophthalmology; 2020 Dec; 127(12):1627-1641. PubMed ID: 32544560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]